CTOs on the Move

Hybrent

www.hybrent.com

 
Purchasing, inventory management and invoicing solutions for healthcare organizations. Integrates with most A/P and clinical software.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hybrent.com
  • 3100, North Clarendon Boulevard
    Arlington, VA USA 22201
  • Phone: 309.808.1324

Executives

Name Title Contact Details

Similar Companies

Rimrock Tech Solutions

Rimrock Technology Solutions is a company that provides cloud-based VoIP phone services, internet services, and website design for businesses.

VOX Network Solutions

Headquartered in the San Francisco Bay Area, VOX Network Solutions is a leading provider of converged voice and data solutions and services that implement, enable and support effective, performance-enhancing business communications capabilities. Our extensive, leading-edge voice and data applications expertise uniquely positions us as a sole-source provider of advanced communication networks to a wide diversity of businesses. At VOX, we excel at planning and design, installation and integration, maintenance and monitoring, IP telephony, unified communications, contact centers, data networking, security, wireless and mobility.

Found Search Marketing

FoundSM is a digital marketing agency in Indianapolis specializing in PPC, Social Ads, SEO, Web Analytics, and Conversion Rate Optimization.

SurveyGizmo

Enterprise Online Survey Software & Tools

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.